The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...
French drug company Sanofi announced it's discontinuing research and development for its next-generation mRNA flu vaccine. The company shared the news in an earnings document, saying it was ending the ...
Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.
The MarketWatch News Department was not involved in the creation of this content. SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 /PRNewswire/ -- Centivax, Inc., a clinical-stage biotechnology company ...
A new study from the University of Gothenburg may help guide the development of better influenza vaccines. Memory cells in ...
Add Yahoo as a preferred source to see more of our stories on Google. Moderna said the FDA's refusal was inconsistent with previous feedback from the agency. - Graham Hughes/Bloomberg/Getty Images The ...
Inside the rigorous, step-by-step process the CDC uses to create pandemic-ready flu vaccine viruses, long before the next global health emergency strikes. Study: Development of pre-pandemic influenza ...
A graduate student at Fred Hutch Cancer Center has produced a near real-time picture of how well the human immune system is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results